Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Infectious Disease
•
Allergy & Immunology
•
Dermatology
•
Internal Medicine
What is your diagnostic approach to mild, chronic eosinophilia with AEC <1500?
When would a patient qualify for anti-IL5 therapy?
How to choose between IL-4, IL-5, or IL-13?
Related Questions
Do you routinely recommend transition to dual PO antibiotic coverage for strep species and MRSA, for patients with purulent cellulitis and in the absence of culture data?
In light of recent measles outbreaks in the US, would you recommend an MMR booster for an immunocompetent patients born before 1957?
What is your experience using sucrosomial iron for symptomatic iron deficient patients who are intolerant of ferrous sulfate and prefer an oral regimen?
How would you manage LPL with associated AL amyloidosis?
What are your vaccine recommendations while patients are on biologics?
What work up do you pursue for a thorough evaluation in patients that present with a potential diagnosis of dermatitis artefacta?
Is it safe to use one TNF inhibitor (e.g., infliximab) in a patient who has had a severe allergic reaction to a different TNF inhibitor (e.g., adalimumab)?
How do you manage recurrent C diff which occurs shortly after FMT when alternate etiologies of diarrhea have been excluded and patient is responding to C diff-directed therapies?
Have you ever seen a case of C. difficile from topical mupiricin?
What is your approach to distinguishing a Jarisch-Herxheimer reaction from a delayed anaphylactoid reaction?